Literature DB >> 35884323

Short-Term Effect of Cigarette Smoke on Exhaled Volatile Organic Compounds Profile Analyzed by an Electronic Nose.

Silvano Dragonieri1, Vitaliano Nicola Quaranta1, Enrico Buonamico1, Claudia Battisti1, Teresa Ranieri1, Pierluigi Carratu2, Giovanna Elisiana Carpagnano1.   

Abstract

Breath analysis using an electronic nose (e-nose) is an innovative tool for exhaled volatile organic compound (VOC) analysis, which has shown potential in several respiratory and systemic diseases. It is still unclear whether cigarette smoking can be considered a confounder when analyzing the VOC-profile. We aimed to assess whether an e-nose can discriminate exhaled breath before and after smoking at different time periods. We enrolled 24 healthy smokers and collected their exhaled breath as follows: (a) before smoking, (b) within 5 min after smoking, (c) within 30 min after smoking, and (d) within 60 min after smoking. Exhaled breath was collected by a previously validated method and analyzed by an e-nose (Cyranose 320). By principal component analysis, significant variations in the exhaled VOC profile were shown for principal component 1 and 2 before and after smoking. Significance was higher 30 and 60 min after smoking than 5 min after (p < 0.01 and <0.05, respectively). Canonical discriminant analysis confirmed the above findings (cross-validated values: baseline vs. 5 min = 64.6%, AUC = 0.833; baseline vs. 30 min = 83.6%, AUC = 0.927; baseline vs. 60 min = 89.6%, AUC = 0.933). Thus, the exhaled VOC profile is influenced by very recent smoking. Interestingly, the effect seems to be more closely linked to post-cigarette inflammation than the tobacco-related odorants.

Entities:  

Keywords:  breath analysis; electronic nose; smoking; volatile organic compounds

Mesh:

Substances:

Year:  2022        PMID: 35884323      PMCID: PMC9313253          DOI: 10.3390/bios12070520

Source DB:  PubMed          Journal:  Biosensors (Basel)        ISSN: 2079-6374


  18 in total

1.  Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.

Authors:  Silvano Dragonieri; Giulia Scioscia; Vitaliano Nicola Quaranta; Pierluigi Carratu; Maria Pia Venuti; Michele Falcone; Giovanna Elisiana Carpagnano; Maria Pia Foschino Barbaro; Onofrio Resta; Donato Lacedonia
Journal:  J Breath Res       Date:  2020-07-21       Impact factor: 3.262

2.  The influence of lifestyle factors on fecal volatile organic compound composition as measured by an electronic nose.

Authors:  Sofie Bosch; Jesse Pm Lemmen; Renée Menezes; René van der Hulst; Johan Kuijvenhoven; Pieter Cf Stokkers; Tim Gj de Meij; Nanne Kh de Boer
Journal:  J Breath Res       Date:  2019-06-25       Impact factor: 3.262

3.  A European Respiratory Society technical standard: exhaled biomarkers in lung disease.

Authors:  Ildiko Horváth; Peter J Barnes; Stelios Loukides; Peter J Sterk; Marieann Högman; Anna-Carin Olin; Anton Amann; Balazs Antus; Eugenio Baraldi; Andras Bikov; Agnes W Boots; Lieuwe D Bos; Paul Brinkman; Caterina Bucca; Giovanna E Carpagnano; Massimo Corradi; Simona Cristescu; Johan C de Jongste; Anh-Tuan Dinh-Xuan; Edward Dompeling; Niki Fens; Stephen Fowler; Jens M Hohlfeld; Olaf Holz; Quirijn Jöbsis; Kim Van De Kant; Hugo H Knobel; Konstantinos Kostikas; Lauri Lehtimäki; Jon Lundberg; Paolo Montuschi; Alain Van Muylem; Giorgio Pennazza; Petra Reinhold; Fabio L M Ricciardolo; Philippe Rosias; Marco Santonico; Marc P van der Schee; Frederik-Jan van Schooten; Antonio Spanevello; Thomy Tonia; Teunis J Vink
Journal:  Eur Respir J       Date:  2017-04-26       Impact factor: 16.671

4.  A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.

Authors:  A Gaida; O Holz; C Nell; S Schuchardt; B Lavae-Mokhtari; L Kruse; U Boas; J Langejuergen; M Allers; S Zimmermann; C Vogelmeier; A R Koczulla; J M Hohlfeld
Journal:  J Breath Res       Date:  2016-04-15       Impact factor: 3.262

Review 5.  The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications.

Authors:  Asad Tamimi; Dzelal Serdarevic; Nicola A Hanania
Journal:  Respir Med       Date:  2011-12-22       Impact factor: 3.415

6.  Identification of lung cancer breath biomarkers based on perioperative breathomics testing: A prospective observational study.

Authors:  Peiyu Wang; Qi Huang; Shushi Meng; Teng Mu; Zheng Liu; Mengqi He; Qingyun Li; Song Zhao; Shaodong Wang; Mantang Qiu
Journal:  EClinicalMedicine       Date:  2022-04-16

7.  Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.

Authors:  Vasiliki Besa; Helmut Teschler; Isabella Kurth; Amir Maqbul Khan; Paul Zarogoulidis; Joerg Ingo Baumbach; Urte Sommerwerck; Lutz Freitag; Kaid Darwiche
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-02-23

8.  Breathing Rhythm Variations during Wash-In Do Not Influence Exhaled Volatile Organic Compound Profile Analyzed by an Electronic Nose.

Authors:  Silvano Dragonieri; Vitaliano Nicola Quaranta; Pierluigi Carratù; Teresa Ranieri; Enrico Buonamico; Giovanna Elisiana Carpagnano
Journal:  Molecules       Date:  2021-05-04       Impact factor: 4.411

9.  The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients.

Authors:  Stefania Principe; Job J M H van Bragt; Cristina Longo; Rianne de Vries; Peter J Sterk; Nicola Scichilone; Susanne J H Vijverberg; Anke H Maitland-van der Zee
Journal:  Molecules       Date:  2021-03-04       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.